Immediate Impact

53 standout
Sub-graph 1 of 23

Citing Papers

Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Cutaneous melanoma
2023 Standout
2 intermediate papers

Works of B. Catteau being referenced

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
2009
[Melanoma in organ transplant patients].
2000

Author Peers

Author Last Decade Papers Cites
B. Catteau 222 122 109 128 125 49 689
Dominique Parent 247 89 66 128 63 55 717
A Puissant 172 134 187 89 75 42 633
Curt P. Samlaska 144 171 78 58 106 31 767
Carmen G. Espinoza 128 87 126 69 160 28 615
F. Cordoliani 184 149 207 95 299 61 838
Hiroshi Fujiwara 115 91 57 70 125 34 695
Anna Jucglá 231 113 87 52 164 36 680
M Bardare 103 72 55 224 159 51 834
Judith Brody 120 91 237 214 120 45 759
Simonetta Di Lollo 67 77 195 79 111 61 806

All Works

Loading papers...

Rankless by CCL
2026